JNPMEDI
JNPMEDI is a South Korea-based digital healthcare company providing the Maven Clinical Cloud platform for end-to-end clinical trial data management, serving pharmaceutical, biotech, and medical device companies through SaaS subscriptions, AI-powered regulatory automation, and CRO professional services.
- Company typePrivate
- Founded2020
- HeadquartersIncheon, South Korea
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What JNPMEDI does
JNPMEDI is a privately held South Korean Life Science RDC (Research, Development, and Commercialization) company founded in 2020 and headquartered in Songdo, Incheon, with a Seoul government-relations office and newly established regional headquarters in Singapore (APAC) and Delaware, USA (AMERICA). The company provides Maven Clinical Cloud, a proprietary end-to-end clinical trial operations and data management platform composed of nine integrated modules: CDMS (data capture), Converter (AI-driven CDISC SDTM transformation), Safety (pharmacovigilance with self-developed FDA AS2 gateway integration), TMF (electronic trial master file), eCOA (decentralized trial patient outcomes), eRecruitment (online subject recruitment), VDR (virtual data room for licensing), Builder (database design), and Coder Express (AWS Bedrock-based NLP medical coding). The platform is supported by an AI Task Force and 'Zero Submission' long-term roadmap targeting regulatory data ecosystems by 2041.
JNPMEDI sells through a combination of recurring SaaS subscriptions (annual enterprise and usage-based tiers), on-demand Professional Services covering business strategy, clinical operations, regulatory affairs (FDA, EMA, PMDA, MFDS), statistical analysis, and licensing-out advisory, plus an AWS Managed Service Provider offering for cloud operations support. Named enterprise customers include Samjin Pharm, Daewoong Pharmaceutical, JW Pharmaceutical, Hurotics, and Microt, primarily Korean pharma and medical device companies pursuing domestic and US/EU regulatory approvals.
The business has scaled rapidly: headcount grew from 20 to 190 in approximately three years, revenue grew 500% in the most recently reported year driven by CRO services expansion, and cumulative funding reached 160 billion KRW led by Pavilion Capital (Temasek subsidiary). The company has assembled regulatory expertise including former FDA reviewers and MFDS veterans, holds CDISC Platinum membership, achieved ISO 13485 certification, and was the first Eastern-region company selected for an official poster session at CDISC EU Interchange 2026. Distribution is reinforced by strategic alliances with Naver (AI and co-investment), MCRA and IQVIA (US market entry), Avance Clinical and ProSciento (Australia/US clinical operations), and academic partnerships across Korean universities for talent development.
JNPMEDI firmographics
Firmographics- Name
- JNPMEDI
- Legal name
- JNPMEDI Inc.
- Website
- https://jnpmedi.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- JNPMEDI is a South Korea-based digital healthcare company providing the Maven Clinical Cloud platform for end-to-end clinical trial data management, serving pharmaceutical, biotech, and medical device companies through SaaS subscriptions, AI-powered regulatory automation, and CRO professional services.
- Ownership category
- akta.pro rank
JNPMEDI industry classification
Industry- Product category
- Clinical Trial Management Software
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)
Keywords
Where JNPMEDI is headquartered
LocationHeadquarters
- HQ city
- Incheon
- HQ country
- South Korea
- HQ region
- Asia
Offices4 records
Markets served
JNPMEDI business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Software Subscriptions (SaaS): Maven Clinical Cloud platform subscriptions with usage-based and tiered pricing models. Includes CDMS, Safety, eCOA, TMF, and other clinical trial management modules.
- Professional Services: Clinical trial consulting, regulatory strategy (FDA, CE, MFDS), clinical operations, data management, statistical analysis, and project management services.
- AWS MSP Services: Cloud management and optimization services for pharmaceutical and biotech companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription with full platform access |
| Usage-based | Pay-as-you-go | Usage-based model for smaller clients |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
JNPMEDI product offering
Product offeringCore offering
JNPMEDI sells the Maven Clinical Cloud, a proprietary cloud platform for clinical trial data collection, management, and regulatory submission (including CDMS, SDTM Converter, Safety/pharmacovigilance, eTMF, eCOA, eRecruitment, VDR, and AI medical coding modules). It wraps this platform with on-demand Professional Services covering clinical operations, regulatory strategy (FDA, CE, MFDS), and licensing support, plus AWS Managed Service Provider offerings, for pharmaceutical, biotech, and medical device clients.
Product overview
JNPMEDI is a Life Science RDC (Research, Development, and Commercialization) company offering a unified platform architecture centered on Maven Clinical Cloud, with integrated modules including Maven CDMS (data collection/management), Maven Converter (SDTM data transformation), Maven Safety (pharmacovigilance reporting), Maven TMF (document management), Maven eCOA (decentralized trials), Maven eRecruitment (patient recruitment), Maven VDR (secure data room), Maven Coder Express (AI medical coding), and Maven Builder (database design). The company also provides Professional Services and AWS MSP Service as complementary offerings, enabling pharmaceutical, biotech, and medical device companies to advance products from business strategy through clinical trials, regulatory approval, and commercialization.
Differentiator
Problem solved
Functional benefit
Brands
- Maven Clinical Cloud: Proprietary end-to-end clinical trial operations and data management cloud platform supporting CDMS, eTMF, Safety, eCOA, and eRecruitment modules.
- Maven CDMS
- Maven Converter
- Maven Safety
- Maven TMF
- Maven eCOA
- Maven eRecruitment
- Maven Builder
- Maven Coder Express
- Maven VDR
- JNPMEDI CONNECT
- JNPMEDI Partners
- FDA Expert Solution
Products and services
- Maven Clinical Cloud Proprietary end-to-end clinical trial operations and data management cloud platform supporting pharmaceutical, biotech, and medical device companies across the clinical lifecycle from protocol design to regulatory submission and commercialization.
- Maven eRecruitment Online clinical trial subject recruitment platform that enables efficient enrollment of participants for clinical studies, particularly in decentralized clinical trial settings.
- Maven Safety Drug safety and pharmacovigilance management solution that reports adverse events and safety data to regulatory agencies following ICH E2B(R3) standards, with self-developed FDA AS2 gateway integration.
- Maven Converter AI-powered solution that automatically transforms raw EDC clinical data into CDISC SDTM international standards format with statistical analysis automation for regulatory submissions.
- Maven Coder Express AI-powered medical coding solution using Amazon Bedrock and NLP for automated MedDRA coding of adverse events and medical terminology in clinical trial data.
- Maven TMF Cloud-based electronic Trial Master File (eTMF) solution for managing and organizing clinical trial documentation with improved operational efficiency.
- Maven CDMS (Clinical Data Management System) Clinical trial data collection and management system for gathering and managing clinical trial data throughout the study lifecycle.
- Maven eCOA (Electronic Clinical Outcome Assessment) Electronic Clinical Outcome Assessment solution for decentralized clinical trials (DCT), enabling remote patient-reported data collection and monitoring.
- Maven VDR (Virtual Data Room) Virtual Data Room solution optimized for pharmaceutical and biotech licensing, enabling secure document and data exchange with enhanced information asset security.
- Maven Builder User-friendly clinical database design solution for efficient setup and configuration of clinical trial data systems.
- Professional Services On-demand solutions covering business strategy, product development, clinical research, regulatory approval (FDA, CE, MFDS), and licensing-out for pharmaceutical, biotech, and medical device products.
- AWS MSP Service AWS Managed Service Provider offering cloud operations support — security, cost optimization, and scalability — for pharmaceutical and biotech digital transformation.
Quantifiable outcome
- Revenue growth of 500% in the previous year
- +2 more outcomes
Companies that use JNPMEDI
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
JNPMEDI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability8 records
Feature10 records
JNPMEDI partnerships and signals
Strategic signalPartnerships
23 partnerships are on record, tiered core and minor.
- NavercoreAI-based digital healthcare global expansion collaboration. Combines JNPMEDI's clinical trial platform with Naver's AI technology to strengthen global competitiveness and investment cooperation for promising domestic companies.
- 휴로틱스 (Hurotics)coreJoint clinical trials and global certification for soft wearable rehabilitation robot 'H-Medi' based on Maven Clinical Cloud. Focus on hip surgery rehabilitation, new medical technology certification, and global market entry.
- 제이앤피메디파트너스coreDemo Day 2025 event for pharma/biotech/medical device startups and domestic/international investors. Biotech Ventures School collaboration with FMI.
- 오니메이드 & 쿠리오사minorThird Daewon Pharmaceutical Open Innovation program selection for clinical data solutions.
- Daewoong PharmaceuticalminorOpen innovation collaboration with Daewoong Pharmaceutical for clinical data solutions.
- MCRA & IQVIAcoreFirst practical workshop collaboration for domestic medical device companies' US market entry. Covers FDA approval, insurance reimbursement, and clinical strategy.
- 오픈리서치minorAI-based medical information intelligence joint research MOU for data-based innovation technology development.
- 경희대학교 약학대학minorRegulatory science and pharmacy talent development MOU including practical training, seminars, guest lectures, and talent recruitment programs.
- 비에스리서치 (BS Research)coreJoint clinical research and global market entry for biocompatibility surface modification technology. Includes domestic clinical trials, CE/FDA certification preparation, and breast implant development.
- 미래의학연구재단 (FMI)coreClinical approval and investment cooperation for pharmaceutical and medical device companies. Focus on commercialization support and global market competitiveness.
- 원주의료기기테크노밸리 (WMIT)minorGangwon region medical device industry development promotion. Includes information sharing, joint software development, healthcare data legal advice, and consulting support.
- 유타대학교 아시아캠퍼스minorKorea-US pharma/biotech industry activation partnership using global networks for clinical trial and FDA approval support.
- MCRAcoreCollaboration with global regulatory specialist MCRA in the US market. FDA reviewer recruitment as foundation for various vendor partnerships for local operations.
- 마이크로트 (Microt)coreFDA 510(k) approval collaboration for A-Stream micro glaucoma implant using Maven Clinical Cloud for clinical data management and regulatory compliance.
- 메디라마coreAnti-cancer drug development full-cycle service combining JNPMEDI's Maven Clinical Cloud with Medirema's ABCD platform. End-to-end drug development support.
- KIMCocoreGlobal new drug R&D platform development partnership for domestic biotech industry international competitiveness.
- 솔루엠 헬스케어minorCancer diagnosis solution development partnership for AI-based diagnostic technology collaboration.
- 넥스트바이오메디컬minorGlobal competitiveness enhancement and technology cooperation for endoscopy AI development.
- 아방스 클리니컬 (Avance Clinical)coreGlobal clinical trial competitiveness enhancement MOU with Australian CRO. Support for domestic pharma/biotech companies' Australian early-stage clinical trials and global expansion.
- CMAX Clinical ResearchminorKorea-Australia clinical trial business expansion MOU with Australia's largest clinical research center.
- ProScientominorMOU for joint solution expansion and service enhancement in the US market with US-based CRO.
- 한림대학교 산학협력단minorThree-party MOU including Hallym University Chuncheon Sacred Heart Hospital for CRO professional talent development and medical industry advancement.
- 강원대학교 산학협력단minorBio innovation startup ecosystem activation and global bio industry development MOU.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
JNPMEDI competitors and assessment
Company assessmentDirect peers
- Saama Technologies: AI-driven clinical trial data management and analytics platform; closely comparable to JNPMEDI's positioning around AI-augmented clinical data workflows and CDISC-ready pipelines.
- Signant Health: Provides eCOA, EDC, IRT, and patient engagement solutions for clinical trials. Direct overlap with Maven eCOA, CDMS, and decentralized trial offerings.
- Clario: Specialist in eCOA, cardiac safety, and clinical endpoint technology — directly comparable to JNPMEDI's Maven eCOA module and DCT-related capabilities.
- Medidata Solutions (Dassault Systèmes): Rave EDC, CTMS, eCOA and the Medidata AI Intelligent Trials suite directly compete with Maven CDMS, eCOA, and AI-driven automation. Closest comparable product set in clinical trial informatics.
- ArisGlobal: Life sciences platform covering pharmacovigilance (LifeSphere Safety), regulatory, and clinical operations. Closely comparable to JNPMEDI's Maven Safety and broader regulatory-focused modules.
- Medrio: Cloud-native EDC and eClinical platform for Phase I-III trials, including ePRO/eCOA modules. Comparable to Maven CDMS for mid-market sponsors with simpler, faster deployment.
Emerging players
- Castor: Modern cloud EDC platform focused on accessibility and decentralized trials. Smaller and more focused than JNPMEDI but similar in targeting digital-first sponsors and DCT use cases.
Broad incumbents
- IQVIA: Global CRO with proprietary clinical technology (EDC, analytics) and a partner of JNPMEDI for US market workshops. Overlaps with JNPMEDI on both the CRO services side and the technology platform side.
- Veeva Systems: Largest pure-play life sciences cloud platform with Veeva Vault CTMS, eTMF, and CDB offerings that directly overlap with JNPMEDI's Maven modules. Far larger and broader portfolio, but a benchmark competitor in regulated pharma cloud.
- Oracle Clinical One: Oracle's unified EDC/CTMS/eTMF platform competes head-to-head with Maven Clinical Cloud, with Oracle's enterprise sales reach and broader life sciences portfolio as advantages.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
JNPMEDI social profiles
Digital presenceJNPMEDI compliance and trust
Trust signalCompliance1 record
JNPMEDI financial estimates
Financial estimateRevenue estimate
Valuation estimate
JNPMEDI leadership team
Management profileNumber of profiles
Profiles13 records
JNPMEDI subsidiaries and ownership
Company hierarchySubsidiaries2 records
JNPMEDI funding detail
Funding detailFunding overview
Funding rounds7 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JNPMEDI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JNPMEDI
What does JNPMEDI do?
JNPMEDI sells the Maven Clinical Cloud, a proprietary cloud platform for clinical trial data collection, management, and regulatory submission (including CDMS, SDTM Converter, Safety/pharmacovigilance, eTMF, eCOA, eRecruitment, VDR, and AI medical coding modules). It wraps this platform with on-demand Professional Services covering clinical operations, regulatory strategy (FDA, CE, MFDS), and licensing support, plus AWS Managed Service Provider offerings, for pharmaceutical, biotech, and medical device clients.
Is JNPMEDI a public or private company?
JNPMEDI is a private company. It is classified as venture growth investor backed and is currently operating.
When was JNPMEDI founded?
JNPMEDI was founded in 2020. It employs 51 to 100 people.
Where is JNPMEDI based?
JNPMEDI is headquartered in Incheon, South Korea, in the Asia region.
How does JNPMEDI make money?
Three revenue lines are on record. Software Subscriptions (SaaS) is the primary driver. The others are professional Services and AWS MSP Services.
Who are JNPMEDI's main competitors?
Direct peers on record are Saama Technologies, Signant Health, Clario, Medidata Solutions (Dassault Systèmes), ArisGlobal and Medrio. Castor is listed as an emerging player. Broad incumbents are IQVIA, Veeva Systems and Oracle Clinical One.
Does JNPMEDI have an API?
No public API is recorded for JNPMEDI.
What industry is JNPMEDI in?
JNPMEDI's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGACAL, Site Data Management Support (EDC/Source/SDV Readiness). Its NAICS code is 5417 and its SIC code is 8731.